Physician profile
Imad N Uddin
NPI 1245498906
$1,027.72
in general payments reported to CMS, 2019-2025
18 companies · $868 in 2025
The $868 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.05 · 2021: $19.26 · 2022: $60.06 · 2024: $13.16 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $184.04 | 2025 | |
| Pfizer INC. | $114.47 | 2024-2025 | |
| Lundbeck LLC | $94.97 | 2019-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $83.93 | 2025 | Austedo Xr, Ajovy |
| Sk Life Science, INC. | $74.66 | 2022-2025 | |
| Merz Pharmaceuticals, LLC | $71.37 | 2025 | Xeomin |
| Axsome Therapeutics, INC. | $57.35 | 2025 | Symbravo |
| Grifols USA, LLC | $50.57 | 2025 | Gamunex-C |
| Abbvie INC. | $47.71 | 2025 | |
| Lilly USA, LLC | $37.49 | 2022-2025 | Kisunla |
| Azurity Pharmaceuticals, INC. | $37.32 | 2025 | Horizant |
| Ucb, INC. | $36.19 | 2025 | Nayzilam, Briviact |
| Ani Pharmaceuticals, INC. | $36.04 | 2025 | Purified Cortrophin Gel |
| Emd Serono, INC. | $30.01 | 2025 | |
| Eisai INC. | $23.36 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $19.12 | 2019 | |
| Amgen INC. | $16.11 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imad Uddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.